Shares of Olaplex Holdings, Inc. (NASDAQ:OLPX – Get Free Report) have been assigned an average recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $1.9229.
Several research analysts have recently weighed in on OLPX shares. Barclays upped their target price on shares of Olaplex from $1.75 to $2.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 14th. Zacks Research upgraded shares of Olaplex from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 12th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Olaplex in a research report on Tuesday, April 21st.
Read Our Latest Research Report on OLPX
Olaplex Stock Performance
Olaplex (NASDAQ:OLPX – Get Free Report) last issued its quarterly earnings data on Monday, May 11th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. The company had revenue of $99.37 million during the quarter, compared to the consensus estimate of $94.11 million. Olaplex had a negative net margin of 3.53% and a positive return on equity of 2.23%. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. As a group, sell-side analysts expect that Olaplex will post 0.09 EPS for the current fiscal year.
Insider Activity at Olaplex
In related news, insider Trisha L. Fox sold 16,324 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $2.04, for a total value of $33,300.96. Following the transaction, the insider owned 1,064,039 shares in the company, valued at approximately $2,170,639.56. The trade was a 1.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 4.80% of the company’s stock.
Institutional Investors Weigh In On Olaplex
Hedge funds and other institutional investors have recently bought and sold shares of the business. Credit Industriel ET Commercial bought a new stake in shares of Olaplex in the first quarter worth $989,000. PSquared Asset Management AG acquired a new stake in Olaplex in the first quarter valued at $2,874,000. GABELLI & Co INVESTMENT ADVISERS INC. bought a new position in Olaplex during the 1st quarter valued at $954,000. ABC Arbitrage SA acquired a new position in Olaplex during the 1st quarter worth $265,000. Finally, Abel Hall LLC grew its holdings in Olaplex by 44.6% during the 1st quarter. Abel Hall LLC now owns 28,663 shares of the company’s stock worth $58,000 after acquiring an additional 8,845 shares in the last quarter. 87.37% of the stock is currently owned by hedge funds and other institutional investors.
Olaplex Company Profile
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
Further Reading
- Five stocks we like better than Olaplex
- Circle’s IBM Patent Deal Could Redraw the Stablecoin Infrastructure Race
- Survey Reveals: 62% of US Households Are Cutting Back on Protein as Grocery Prices Rise [2026]
- UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
